GlassScriptPhysician profile
Jessica C Charest
NPI 1093009185
$8,662.98
in general payments reported to CMS, 2019-2025
28 companies · $655 in 2025
The $655 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,679 · 2020: $63.11 · 2021: $308 · 2022: $304 · 2023: $329 · 2024: $325 · 2025: $655.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,309.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,308.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,453.20 | 2019 | |
| Abbvie INC. | $348.93 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Hologic Sales and Service, LLC | $285.46 | 2019-2025 | Myosure Tissue Removal Device, Novasure |
| Pfizer INC. | $241.21 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $199.24 | 2023-2025 | Myfembree |
| Pacira Pharmaceuticals Incorporated | $185.64 | 2021-2024 | Exparel |
| Astellas Pharma US INC | $156.67 | 2023-2025 | Veozah |
| Shield Therapeutics INC | $125.26 | 2022-2025 | |
| Gynesonics, INC. | $98.91 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Sage Therapeutics, LLC | $94.50 | 2024-2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $67.23 | 2022-2023 | |
| Avanos Medical | $65.32 | 2019-2024 | On-Q* Pump and Accessories |
| Allergan, INC. | $32.90 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $31.89 | 2019 | |
| Myovant Sciences INC. | $30.77 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $30.22 | 2022-2024 | |
| Abbott Laboratories | $22.76 | 2025 | Proclaim |
| Vertical Pharmaceuticals, LLC | $22.12 | 2019 | |
| Nalu Medical, INC. | $20.87 | 2025 | Nalu Neurostimulation System |
| Vertex Pharmaceuticals Incorporated | $20.76 | 2025 | |
| Integra Lifesciences Corporation | $20.39 | 2025 | Cusa Clarity, Codman Hakim, Codman Certas |
| Therapeuticsmd, INC. | $17.92 | 2022 | |
| Supernus Pharmaceuticals, INC. | $16.61 | 2025 | Qelbree |
| Exeltis, USA INC. | $15.89 | 2024 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $15.50 | 2022 | |
| Amgen INC. | $14.79 | 2019 | |
| Lupin INC. | $14.23 | 2019 | |
| Medtronic, INC. | $13.79 | 2025 | Ligasure |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Charest listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.